Back to results
US 2021/0275507 A1Published application
Methods of treating hepatic encephalopathy
AssigneeSalix Pharmaceuticals, Inc.
InventorWilliam Forbes
Life of this patent
Estimating the term…
Abstract
The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin.
Claims11
1-96. (canceled)
A method of increasing the time to development of spontaneous bacterial peritonitis (SBP) in a hepatic encephalopathy patient, comprising administering to the subject 550 mg of rifaximin to the subject two times per day (BID).
Dependencies are inferred from the claim text.